• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Matthew Perrone

Stay informed with Matthew Perrone’s coverage and analysis.

FDA will not make a decision on Merck’s COVID antiviral pill until December
HealthFDA will not make a decision on Merck’s COVID antiviral pill until December
By Matthew Perrone and The Associated PressOctober 14, 2021
FDA debates timeline for administering Johnson & Johnson booster shots
HealthFDA debates timeline for administering Johnson & Johnson booster shots
By Matthew Perrone, Lauran Neergaard and The Associated PressOctober 13, 2021
FDA panel will advise on Johnson & Johnson booster shots this week
HealthFDA panel will advise on Johnson & Johnson booster shots this week
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 12, 2021
Merck asks FDA to authorize its breakthrough COVID antiviral pill
HealthMerck asks FDA to authorize its breakthrough COVID antiviral pill
By Matthew Perrone and The Associated PressOctober 11, 2021
Merck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
HealthMerck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
By Matthew Perrone and The Associated PressOctober 1, 2021
FDA backs Pfizer COVID-19 boosters for seniors and high-risk
HealthFDA backs Pfizer COVID-19 boosters for seniors and high-risk
By Matthew Perrone, Lauran Neergaard, Mike Stobbe and The Associated PressSeptember 22, 2021
The fate of Biden’s ambitious COVID booster plan lies in the hands of FDA advisors
HealthThe fate of Biden’s ambitious COVID booster plan lies in the hands of FDA advisors
By Matthew Perrone, Lauran Neergaard and The Associated PressSeptember 17, 2021
FDA strikes neutral tone ahead of Friday’s COVID vaccine booster meeting
HealthFDA strikes neutral tone ahead of Friday’s COVID vaccine booster meeting
By Lauran Neergaard, Matthew Perrone and The Associated PressSeptember 15, 2021
FDA delays decision on whether Juul can remain on the market
HealthFDA delays decision on whether Juul can remain on the market
By Matthew Perrone and The Associated PressSeptember 9, 2021
Pfizer COVID-19 vaccine gets full approval from U.S. FDA
HealthPfizer COVID-19 vaccine gets full approval from U.S. FDA
By Lauran Neergaard, Matthew Perrone and The Associated PressAugust 23, 2021
U.S. health officials call on Americans to get COVID-19 booster shots
HealthU.S. health officials call on Americans to get COVID-19 booster shots
By Mike Stobbe, Matthew Perrone and The Associated PressAugust 18, 2021
The FDA says Americans with weakened immune systems can now get a Pfizer or Moderna booster shot
HealthThe FDA says Americans with weakened immune systems can now get a Pfizer or Moderna booster shot
By Lauran Neergaard, Matthew Perrone and The Associated PressAugust 13, 2021
Moderna will expand its child COVID vaccine study to better detect side effects
HealthModerna will expand its child COVID vaccine study to better detect side effects
By Matthew Perrone, Linda Johnson and The Associated PressJuly 27, 2021
FDA announces plan to ban menthol cigarettes
HealthFDA announces plan to ban menthol cigarettes
By Matthew Perrone and The Associated PressApril 29, 2021
Vaping Industry Gets a Minty Respite From Trump’s Flavor Ban
RetailVaping Industry Gets a Minty Respite From Trump’s Flavor Ban
By Matthew Perrone and The Associated PressJanuary 2, 2020
1...
  • 4
  • 5
  • 6
  • 7
  • 8
8
Most Popular
Success
Elon Musk on MacKenzie Scott giving away $26 billion of her fortune: 'Sadly,' it makes the world a worse placeplaceholder alt text
By Sydney LakeJune 29, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.